Arrowhead Pharmaceuticals Inc (ARWR)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 62.55M | 146.27M | 15.83M | 16.1M | 3.55M | 0 | 0 | 0 |
営業利益 | -42.13M | 48.17M | -102.7M | -108.33M | -136.55M | -126.19M | -176.14M | -162.2M |
税引前収入 | -41.79M | 47.68M | -103.38M | -108.99M | -138.69M | -127M | -173.98M | -172.8M |
純利益 | -41.33M | 48.68M | -102.95M | -109.68M | -132.86M | -125.3M | -170.79M | -170.54M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -41.63M | 48.17M | -102.4M | -107.61M | -136.12M | -126M | -175.38M | -163.95M |
EBITDA | -39.45M | 50.83M | -99.43M | -104.47M | -132.28M | -121.67M | -171.36M | -157.18M |
年末 2024年9月30日 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 31.41M | 16.14M | 168.8M | 87.99M | 138.29M | 243.23M | 240.74M | 3.55M |
営業利益 | -37M | -55.94M | 61.19M | -93.16M | -149.04M | -178.51M | -205M | -601.08M |
税引前収入 | -34.38M | -54.45M | 68.15M | -84.55M | -140.85M | -172.71M | -206.49M | -612.46M |
純利益 | -34.38M | -54.45M | 67.98M | -84.55M | -140.85M | -176.06M | -205.28M | -599.49M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.46 | -0.615 | 0.712 | -0.826 | -1.35 | -1.661 | -1.915 | -4.822 |
EBIT | -35.68M | -55.93M | 61.19M | -93.74M | -146.97M | -177.74M | -203.46M | -602.83M |
EBITDA | -32.31M | -51.24M | 65.63M | -87.22M | -140.77M | -168.09M | -192.51M | -582.49M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約